07:00 , Sep 8, 2008 |  BC Week In Review  |  Company News

Exosome Diagnostics management update

Exosome Diagnostics Inc. , New York, N.Y.   Business: Diagnostic   Hired: Wayne Comper as CSO, formerly CSO of AusAm Biotechnologies Inc.  ...
08:00 , Mar 27, 2006 |  BC Week In Review  |  Company News

AusAm, Keryx deal

KERX acquired AusAm's Accumin urinary albumin diagnostic for 200,000 shares, which are valued at $3.6 million using KERX's close of $18 on March 22, the day before the deal was announced. AusAm also is eligible...
08:00 , Jan 3, 2005 |  BC Week In Review  |  Company News

AusAm, Quest Diagnostics sales and marketing update

DGX will sell AusAm's Accumin albumin urine test to U.S. hospitals. The test is expected to be launched in the first quarter. AusAm Biotechnologies Inc. , Santa Monica, Calif.   Quest Diagnostics Inc. (DGX), Teterboro,...
07:00 , Aug 9, 2004 |  BC Week In Review  |  Company News

AusAm management update

AusAm Biotechnologies Inc. , Santa Monica, Calif.   Business: Infectious, Diagnostic   Hired: Mark Straley as COO, formerly VP and general manager of diagnostics at Bayer AG  ...
08:00 , Mar 1, 2004 |  BC Week In Review  |  Company News

AusAm, National Institute of Health deal

The NIH awarded AusAm a contract grant to develop its DES10 topical microbicide to prevent HIV, herpes and other sexually transmitted diseases. The company and institute will collaborate on preclinical models to identify the antiviral...
08:00 , Feb 23, 2004 |  BC Week In Review  |  Company News

AusAm board of directors update

AusAm Biotechnologies Inc. , Santa Monica, Calif.   Business: Diagnostic   Appointed: James Chambers, principal at Conundrum Capital Partners LLC; Glenn Sherman, managing general partner at Northshore Asset Management  ...
07:00 , Oct 20, 2003 |  BC Week In Review  |  Clinical News

Microalbumin Plus test regulatory update

The EMEA granted marketing clearance for AusAm's Microalbumin Plus quantitative urinary albumin test to diagnose kidney and cardiovascular diseases. The FDA approved the test in August. AusAm Biotechnologies Inc. , Santa Monica, Calif.   Product:...
07:00 , Sep 1, 2003 |  BC Week In Review  |  Clinical News

Microalbumin Plus test regulatory update

The FDA granted marketing approval for AusAm's Microalbumin Plus quantitative urinary albumin diagnostic test to diagnose kidney and cardiovascular diseases. AusAm Biotechnologies Inc. , Santa Monica, Calif.   Product: Microalbumin Plus test   Business: Diagnostic...
07:00 , Aug 26, 2002 |  BC Week In Review  |  Company News

AusAm, Esoterix Inc. deal

The companies partnered to develop and market AusAm’s quantitative urinary albumin diagnostic test to detect early kidney disease in the North American clinical reference laboratory market. AusAm will be responsible for securing regulatory approval of...